Absorption of 5'-deoxy-5-fluorouridine from colon.
Rectally administered 5'-deoxy-5-fluorouridine (dFUR) is active against transplanted dimethylhydrazine-induced colon tumor in rats. This study investigated the disposition of dFUR in normal non-tumor-bearing rats after rectal administration (350 or 700 mg/kg). An intravenous (iv) bolus injection of [5'-3H]dFUR (28.2 muCi, 0.43 micrograms) was given 5 min after the rectal dose (700 mg/kg) to determine the dFUR clearance (CL). Blood and fecal samples were analyzed by high-pressure liquid chromatography and liquid scintillation. After the iv tracer dose, the CL was 19 ml/min/kg and the terminal half-life was 50 min. After a 700-mg/kg rectal dose, the terminal half-life was 430 min, the bioavailability was 30%, and the fraction of the dose recovered in 24-hr feces was 34%. After a 350-mg/kg dose, absorption was apparently not completed at 12 hr, as indicated by a lack of decline in blood concentration. The bioavailability of the 350-mg/kg dose exceeded 16%. The absorption of dFUR (700 mg/kg) from the colon was analyzed by the Loo-Riegelman method: the absorption half-life was 550 min. The terminal half-life after the rectal dose was much slower than that after the iv tracer dose but similar to the absorption half-life. These data indicate that dFUR was absorbed from the colon, that the absorption process was the rate-limiting step of its disposition after rectal administration, and that the slow absorption gave a sustained drug concentration in blood.
Au
J L
JL
College of Pharmacy, Ohio State University, Columbus 43210.
Gunnarsson
L C
LC
D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D001682:Biological Availability; D003106:Colon / Q000378:metabolism*; D005243:Feces / Q000032:analysis; D005260:Female; D005467:Floxuridine / Q000493:pharmacokinetics*; D007408:Intestinal Absorption; D051381:Rats; D014018:Tissue Distribution
D000970:Antineoplastic Agents; D005467:Floxuridine; C025034:doxifluridine